Helix Exploration buys Keyes Helium Complex in $11m deal and launches £17.6m fundraising to move from raw gas seller to full-chain helium processor.
This article covers information on Helix Exploration PLC.
LON:HEXLast updated:
Helix Exploration has announced a conditional deal to acquire the Keyes Helium Complex in Oklahoma for US$11 million, while also launching a Placing to raise up to £16 million and a Retail Offer of up to £1.6 million. In plain English, Helix wants to stop being just a producer of raw helium and become a company that can process, liquefy and sell a higher-value product.
That is the big idea here. If it works, Helix gets closer to capturing the full profit margin from the wellhead through to liquid helium delivery, rather than handing some of that value to third-party processors further down the chain.
| Item | Figure |
|---|---|
| Acquisition price for Keyes Helium Complex | US$11 million |
| Cash consideration | US$10 million |
| Share consideration | US$1 million |
| Consideration shares | 2,023,280 shares |
| Consideration share price | 37 pence |
| Placing size | Up to £16 million |
| Retail Offer size | Up to £1.6 million |
| Issue price | 22 pence |
| Discount to 2 July closing mid-price | 15.4% |
| Keyes revenue for 5 months to 31 May 2026 | US$2.91 million |
| Keyes EBITDA for 5 months to 31 May 2026 | US$1.42 million |
| Planned new Rudyard wells | 4 wells |
| Target cost per new well | US$1.0 million |
This is not a bolt-on side deal. It looks like a serious strategic step.
Helix currently produces raw helium at Rudyard in Montana. By owning the Keyes purification and liquefaction plant in Oklahoma, it can potentially upgrade that helium into liquid helium, which usually attracts better pricing because it is usable in critical end markets such as MRI scanners, semiconductors, aerospace and cryogenics.
The company is also making a scarcity argument. It says Keyes is one of only six operational US helium liquefaction facilities and is independent of the major industrial gas companies. If true in practice, that gives the asset strategic value beyond its current earnings.
There is another important angle here: tolling. That means Helix can process helium for third parties for a fee, rather than only using the plant for its own production. That opens an extra revenue stream and could smooth out risk if its own output fluctuates.
The company says it is acquiring Keyes at a c.65% discount to an estimated replacement cost of around US$31 million, plus or minus 20%. On paper, that sounds very attractive. Buying existing infrastructure cheaply is usually much better than trying to build it from scratch, especially when management says a new comparable facility could take more than five years and face tougher permitting hurdles.
There is also evidence the asset is not just theoretical value. The Keyes Helium Complex and Keyes Gathering system generated US$2.91 million of revenue and US$1.42 million of EBITDA in the five months ended 31 May 2026. EBITDA is earnings before interest, tax, depreciation and amortisation – basically a rough measure of operating profitability before financing and accounting charges.
That said, investors should keep their feet on the ground. Those numbers are unaudited, and the RNS does not disclose the full long-term maintenance profile, capex needs beyond the initial upgrades, or the exact terms of the tolling contracts. So yes, it looks promising, but it is not risk-free.
The fundraising is about more than just paying for the acquisition. Helix is trying to fund the next stage of growth in one go.
That last bit matters. Helix says it currently has three production wells connected to its on-site PSA facility and is connecting a fourth well, Inez. Once that happens, the current membrane capacity will have been reached at prudent flow rates of 1,500 mcf/day. So the company is not just drilling more wells for the sake of it – it is also spending to remove a processing bottleneck.
From an investor point of view, that is sensible capital allocation. More wells without enough processing capacity would be a waste. Helix appears to be funding both the supply growth and the kit needed to handle it.
The new shares are being issued at 22 pence, a 15.4% discount to the closing mid-market price of 26 pence on 2 July 2026. That discount is not outrageous for a small-cap growth fundraising, but it is still dilution. Existing shareholders are giving up a slice of the company to fund this expansion.
There is also no safety net here because the fundraising is not underwritten. That means if demand falls short, the company does not have a third party guaranteeing the money. The Placing is being done through an accelerated bookbuild, so the market will decide quickly how much support there really is.
The Retail Offer is a decent gesture. It gives retail investors the chance to participate at the same 22 pence price, rather than being left on the sidelines while institutions get the deal.
One of the more interesting parts of the RNS is Drachs Investments No.3 Ltd, already the largest shareholder, indicating it intends to invest around £7 million in the Placing. That is a strong signal of support.
But support comes with strings attached. Assuming the full £17.6 million is raised and Drachs participates as indicated, it would own about 18.8% of the enlarged share capital. It would then be entitled to appoint two non-executive directors and one board observer, subject to holding thresholds.
That is not automatically a bad thing. A committed cornerstone investor can bring stability and oversight. But it does mean influence over the board becomes more concentrated, and investors should watch that carefully.
My read is that this is a bold and mostly positive move. Helix is trying to turn itself from a small upstream helium producer into a more integrated helium business with better pricing power, more diversified revenues and strategically useful infrastructure.
The numbers in the RNS help the case. The plant already has revenue, EBITDA, existing tolling relationships and replacement value that appears far above the purchase price. The Rudyard drilling plan also suggests management wants to push production growth quickly rather than wait for internal cash flow to dribble in.
The negatives are the usual ones for a company at this stage: dilution, execution risk, integration risk and reliance on future helium market strength. Investors also need to remember that several of the most attractive claims here – stronger margins, global buyer reach, better contract terms and collaboration opportunities – are still forward-looking rather than proven.
Still, if you wanted one sentence on what this RNS means, it is this: Helix is raising a lot of money because it thinks owning scarce helium infrastructure now could materially increase its long-term value. That is an ambitious bet, and for now the market will decide whether it buys the story.
So this will move fast. The strategic logic is clear enough. Now Helix needs to prove it can close the deal, bed in the asset, expand Rudyard and convert a good narrative into cash flow.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
10 viewsLikes
No ratings yet
No comments yet - start the conversation.